OrthoPediatrics Corp

KIDS

Add to Watchlist

17.720USD

-0.180-1.01%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

OrthoPediatrics Corp's Score

Industry at a Glance

Industry Ranking

37 / 206

Overall Ranking

115 / 4482

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

OrthoPediatrics Corp Highlights

StrengthsRisks

OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 58.91% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 236.35M.

Fairly Valued

The company’s latest PE is -10.53, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 18.35M shares, decreasing 1.93% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 26.56K shares of this stock.

Analyst Rating

Based on 9 analysts

Buy

Current Rating

24.667

Target Price

+37.80%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of OrthoPediatrics Corp is 6.78, ranking 111 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 59.36M, representing a year-over-year increase of 13.26%, while its net profit experienced a year-over-year increase of 0.26%.

Score

Industry at a Glance

Previous score

6.78

Change

0



Financials

7.91

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

5.51

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.90

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.44

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.15

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of OrthoPediatrics Corp is 7.72, ranking 64 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -10.53, which is -7877.26% below the recent high of 819.12 and -241.57% above the recent low of -35.98.

Score

Industry at a Glance

Previous score

7.72

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 37/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of OrthoPediatrics Corp is 8.22, ranking 56 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 23.00, with a high of 34.00 and a low of 19.00.

Score

Industry at a Glance

Previous score

8.22

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of OrthoPediatrics Corp is 8.98, ranking 24 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 19.37 and the support level at 15.24, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.02

Change

-0.04

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of OrthoPediatrics Corp is 7.00, ranking 80 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 71.44%, representing a quarter-over-quarter increase of 1.26%. The largest institutional shareholder is Wasatch Global Investors, holding a total of 329.32K shares, representing 1.28% of shares outstanding, with 55.76% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Squadron Capital LLC

6.90M

--

Brown Advisory

1.89M

-0.20%

Millennium Management LLC

1.40M

+0.42%

Braidwell LP

1.10M

-0.67%

BlackRock Institutional Trust Company, N.A.

1.08M

-0.44%

Wellington Management Company, LLP

1.02M

-0.47%

Morgan Stanley & Co. LLC

881.82K

-19.76%

Granahan Investment Management, LLC

663.98K

-12.63%

Dimensional Fund Advisors, L.P.

622.42K

-13.53%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of OrthoPediatrics Corp is 5.68, ranking 74 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.02. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

OrthoPediatrics Corp

KIDS

7.56 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.68 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.58 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.37 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment